HighSTEACS

HighSTEACS is a randomised controlled trial, across 10 hospitals in NHS Lothian and NHS Greater Glasgow & Clyde, assessing patient outcomes before and after the implementation of high sensitivity Troponin assay

Research Team

EMERGE Research team
Cardiology Research Group

Aim

HighSTEACS is a randomised controlled trial, across 10 hospitals in NHS Lothian and NHS Greater Glasgow & Clyde, assessing patient outcomes before and after the implementation of high sensitivity Troponin assay. The primary endpoint is the one-year rate of cardiovascular death or recurrent myocardial infarction. Secondary endpoints include length of stay, unplanned coronary revascularisation, recurrent hospital admissions excluding ACS, bleeding events and non-cardiovascular death.  There is also a sub-study at the ED, RIE and in one site in NHS Greater Glasgow and Clyde.

Trial Design

Prospective stepped wedge cluster randomised controlled trial

Eligibility criteria (summary)

Patients who present to the Emergency Department with suspected heart disease

Status: closed

Start Date

June 2014

Coordinated by

University of Edinburgh & NHS Lothian

End date

March 2017